NCT00007917View on ClinicalTrials.gov

Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

September 30, 2010

Study Completion Date

October 31, 2010

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

DRUG

gemcitabine hydrochloride

Trial Locations (2)

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00007917 - Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter